UBS Group’s YD Bio Ltd YDES Stock Holding History

UBS Group’s Portfolio YDES Stock Details YDES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89.5K	Buy	11,628 +4,436	+62%	+$42.8K	﹤0.01%	7052
2025 Q4	$87.7K	Sell	7,192 -3,124	-30%	-$42.2K	﹤0.01%	6967
2025 Q3	$201K	Buy	+10,316	New	+$179K	﹤0.01%	6668

Other funds holding YDES

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group's YDES Position: Q1 2026 in Review

UBS Group increased its YD Bio Ltd (YDES) stake by 62% in Q1 2026, buying an estimated $42.8K and bringing the position to 11,628 shares worth $89.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7052.

UBS Group first reported a position in YDES in Q3 2025 and has held it in 3 quarters since. The position peaked at $201K in Q3 2025. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

UBS Group held 11,628 shares of YD Bio Ltd worth $89.5K as of Q1 2026.
UBS Group bought 4,436 YD Bio Ltd shares in Q1 2026, an estimated $42.8K.
YD Bio Ltd made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7052 holding.
UBS Group first reported a position in YD Bio Ltd in Q3 2025 and has held it in 3 quarters since.
UBS Group's YD Bio Ltd position peaked at $201K in Q3 2025.
8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.